7 results
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
for using anti-infectives ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs ... #pharmacotherapy
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... Ozempic), or daily tablet ... not definitively cause ... Receptor #Agonists #Pharmacology ... DM2 #diabetes #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
#pharmacology #pharmacotherapy ... #table #comparison ... medications #diabetes #endocrinology ... #treatment
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... Tradjenta) - Once/day tablet ... not definitively cause ... DM2 #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... DPP-4 inhibitor, GLP ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... medication in the injection ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Histoplasma Capsulatum Infections ... histoplasmosis (>10 cases ... with ARV (see Table ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology